Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor ageCraig Kollman, Dennis L. Confer|Blood|2001Cited by 701
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2010Cited by 477
One million haemopoietic stem-cell transplants: a retrospective observational studyAloïs Gratwohl, Dietger Niederwieser, Minako Iida et al.|The Lancet Haematology|2015Cited by 434
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, Helen Baldomero, Jeff Szer et al.|Bone Marrow Transplantation|2016Cited by 309
Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.John R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2007Cited by 91